“Cancer may have started the fight, but we will finish it!” Or at least try our best to finish it. Prostate cancer, the second most common cancer in males, is a major health concern for the ageing male. The National Cancer Registry in India has charted an incidence of 10 per 1 lakh males for the year 2018 and has predicted a several fold increase in incidence of this malignancy owing to the increased longevity, lifestyle and environmental changes, increased awareness about the disease, adoption of screening and availability of simple screening methods to detect the disease.
The introduction of measurement of serum Prostate Specific Antigen (PSA) has changed the ball game completely and has allowed us to detect the disease in its infancy through a simple blood test and render our patients free of the disease with the various treatment modalities available. The myriad of available treatment options comprising of hormone therapy, radiation therapy, surgery and chemotherapy alone or in combination have to be used scientifically and rationally and this we have ensured through the latest addition of a specialized uro-oncologist in our team.
Renal or kidney malignancies, though not the most common of all urological cancers, can be the most lethal ones with early propensity for metastases. Several newer medications in the form of tyrosine kinase inhibitors are available for management of metastatic disease in case the primary tumor is inoperable. Cancers of the penis, testes and the bladder are also on a rise, as an epidemic and specialized services are required for the scientific management of the same. We believe that, if detected in time, we are capable of providing cure to our patients, because we have the expertise and the various treatment options that are available worldwide.